With two out of every three people likely to be living in cities or other urban centres by 2050; digital, data, and technology will play an important role in making these settings enjoyable, productive, and sustainable. This is the concept of ‘smart cities’ – urban environments which leverage these tools to deliver better lives and livelihoods for their populations.
Topics: Artificial Intelligence / Deep Learning / Machine Learning / Robotics, MedTech / HealthTech / BioTech
At SGInnovate's upcoming Investors Night, we have invited David Sheppard and Florence Joffroy-Black from MedWorld Advisors to share with us on exit strategies for MedTech startups. They will share the various exit strategies available for MedTech startups at the early, growth and mature stages, as well as the current trends of acquisition by private equity vs strategic buyers. The programme will then be followed by a fireside chat moderated by SGInnovate's Founding CEO, Steve Leonard, and pitches by carefully selected MedTech startups.
In Singapore, life expectancy has risen to about 85 years, and by 2030, it has been predicted that one in four Singaporeans will be aged 65 and above. It is undeniable that Singapore will have a rapidly ageing population; hence, it is imperative to encourage citizens to be as healthy and active as possible.
Topics: Artificial Intelligence / Deep Learning / Machine Learning / Robotics, MedTech / HealthTech / BioTech
Scientifically based disease prevention and health promotion have been made possible by the numerous scientific and technological advances that have redefined medicine in the 21st century. One of the critical influences in this process is the development and use of new medical devices. As in other areas of technological advancement, the benefits of new medical devices are not without cost and a lengthy regulatory process.
Topics: MedTech / HealthTech / BioTech
Singapore, like many other Asian and European countries, is in demographic trouble. With a rapidly ageing population that is living longer, there is an increasing need to provide additional medical services beyond the status quo.
Topics: Artificial Intelligence / Deep Learning / Machine Learning / Robotics, MedTech / HealthTech / BioTech
In the first half of 2019, the total new money entering the Asia Pacific HealthTech sector was US$2.5 billion across 140 deals. And the second quarter of 2019 was the 8th consecutive $1 billion or more quarter for HealthTech in Asia. While the number of deals is going down, the individual deals are getting larger and more likely to be in later-stage companies (Galen Growth Asia 2019 Half Year Asia HealthTech Landscape report).
Presented by SGInnovate and Ecosystm, this event will look at some of the trends that are going to shape the areas of AI, Cybersecurity, Cities of the Future and MedTech in 2020.
Topics: Artificial Intelligence / Deep Learning / Machine Learning / Robotics, MedTech / HealthTech / BioTech, Others
During this holiday reception, APACMed and MedTech Innovator will be sharing milestones underpinning this partnership in the past 12 months. Hear directly from the Founders of this first MedTech Innovator cohort, their MedTech Corporate Mentors; as well as MedTech Innovator finalists who participated in the inaugural APACMed Connected Care Innovation Showcase at MedTech Forum.
Topics: MedTech / HealthTech / BioTech, Startups
Creating knowledge and understanding through science equips us to find solutions to today’s acute economic, social and environmental challenges and to achieving sustainable development and greener societies. From high-tech systems that allow farmers to predict yield and waste to recyclable food packaging material, technology is being harnessed to overcome challenges such as climate change, pollution and the over-consumption of resources.
Topics: MedTech / HealthTech / BioTech
The time has come when our dramatically increased knowledge of the human immune system is finally being exploited into novel and exciting therapies in various diseases.
Topics: MedTech / HealthTech / BioTech
Most people would agree that technology has the potential to bring about tremendous improvements to healthcare delivery. However, to date, digital innovation has brought as much change as it did hype and unrealistic expectations. Artificial Intelligence is but an enabler – among many enablers – that can lead to more precise therapies and more efficient care.
Topics: MedTech / HealthTech / BioTech
Join us on the 21st of this month as we explore the exciting field of cell therapies, including CAR-T and TCR-T cell therapies which display great potential to transform cancer treatment. This event will feature a keynote address by Novartis providing an overview of the topic of cell therapy and global developments in this area. A panel discussion by experts in the field will then delve into the details of the future promise of these therapies as well as current challenges in the field that may still need to be overcome.
Topics: MedTech / HealthTech / BioTech